Medicamen Biotech
MEDICAMEQ · Pharma > Pharmaceuticals & Drugs · Chairman: Rahul Bishnoi Listing date: Oct. 28, 2021

Stock Price vs Company Growth
1d
3.6%
1w
9.8%
1m
16.4%
3m
1.0%
6m
21.8%
1y
24.4%
all
2.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 522 3.6%
357
628
Company Overview

Sales
171 Cr
Growth: 23.8%
Profit after Tax
12.3 Cr
Growth: -12.3%
Small Cap
664 Cr
P/E: 58.5x
Industry P/E: 35.0x
Fundamentals

Sales (Cr) ₹ 171
Growth 23.8%
EBITDA 13.5%
P/S 3.9x
Dividend 0.1%
P/E 58.5x
Book Value ₹ 9.95
PEG Ratio 2.6x
ROE 97.4%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Medicamen Biotech Limited was incorporated in December 1993, it is a widely held, Globaly Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. Medicamen Biotech Limited is committed to produce and provide quality medicines at competitive price for domestic as well as international markets thereby being socially responsible and rendering services to the medical fraternity since inception.
Investors (2)